Clinical Trials Logo

Vertebral Fracture clinical trials

View clinical trials related to Vertebral Fracture.

Filter by:

NCT ID: NCT00638768 Completed - Osteoporosis Clinical Trials

Effectiveness of Physiotherapy for Osteoporotic Spinal Fracture

Start date: February 2006
Phase: Phase 2
Study type: Interventional

The aim of this pilot study was to determine the effect of physiotherapy on impairments and health-related quality of life in people with a painful osteoporotic spinal fracture. It is hypothesised that physiotherapy will reduce impairments and improve quality of life in this patient group.

NCT ID: NCT00635297 Suspended - Osteoporosis Clinical Trials

Percutaneous Vertebroplasty: Prophylactic Treatment of Adjacent Vertebra

Start date: April 2008
Phase: N/A
Study type: Interventional

Percutaneous vertebroplasty is a treatment for painful osteoporotic compression fractures. Multiple reports have shown as high as 20 % refracturerates in vertebrae adjacent to those that have been treated with percutaneous vertebroplasty. The purpose of the study is to determine if prophylactic vertebroplasty of unfractured vertebrae adjacent to the treated fractured vertebrae can reduce the rates of refracture in adjacent vertebrae.

NCT ID: NCT00463905 Completed - Osteoporosis Clinical Trials

Evaluation of the Impact of a Case-finding Strategy for Vertebral Fractures

COSHIBA
Start date: October 2007
Phase: N/A
Study type: Interventional

Postmenopausal women with vertebral fractures (VFs) represent an important target for secondary fracture prevention, but few of these patients come for clinical attention. Recent evidence suggests that screening postmenopausal women for clinical risk factors like height loss and fracture risk identifies those at high risk of prevalent VFs who should be referred for diagnostic X-rays, a strategy which is likely to prove cost effective. However, before being applied at a United Kingdom (UK)-wide level, it needs to be established that use of this strategy improves secondary fracture prevention, and that these benefits are achieved in a cost-effective manner. To examine these questions, a randomised-controlled-trial will be performed in which women aged 65-80 from general practitioner (GP)-practices in the intervention group will be invited for risk factor assessment, followed by referral for thoracolumbar X-ray where appropriate. The primary outcome will be a change in bisphosphonate or other drug prescribing between the intervention and control arms after six months.